SUMMARY OBJECTIVE: Cancer imposes a profound burden on low- and middle-income countries where 65% of the global cancer deaths occurred in 2020. The objective of the present review was to describe female cancer epidemiology in Brazil, barriers to prevention, screening, and treatment, and to propose strategies to a better control. METHODS: For the process of literature search and scientific acquisition, we have utilized the terms “female cancer” AND “breast cancer,” AND “cervical cancer” AND “endometrial cancer” AND “ovarian cancer” AND “Brazil” in PubMed. References of the articles included in this review were manually searched in order to identify relevant studies on the topic. The official Brazilian epidemiology data were extensively analyzed at the governmental site www.inca.gov.br. RESULTS: Considering cases of breast and gynecologic cancers together, 105,770 new cases are expected to be diagnosed yearly, positioning female cancer as the highest cancer incidence in Brazil. Female breast cancer is the most common and the leading cause of death from cancer in the female population in all regions of Brazil, except in the North, where cervical cancer ranks first. Cervical cancer, a preventable disease, corresponds to the third-most common neoplasia in women, with higher incidences in the North and Northeast regions of Brazil. An upward trend has been observed in endometrial cancer incidence, a tendency that follows the increase of its two most common risk factors: population aging and obesity. Ovarian cancer currently occupies the eighth position among female cancers in Brazil, but it is the most lethal gynecologic cancer. The main strategies to reduce female cancer mortality rates are the reduction of inequalities in healthcare services and the early diagnosis of cases. The lack of a specific national cancer program results in a reactive and unplanned approach to healthcare provision, ultimately leading to suboptimal resource utilization and higher expenditure. CONCLUSION: Analyzed together, breast and gynecologic cancers correspond to the leading cause of cancer in Brazil. A heterogeneous group, female cancer includes diseases with a high primary and secondary prevention potential. The organization of a female cancer program in Brazil prioritizing primary and secondary prevention strategies, such as adequate mammography screening and human papillomavirus vaccination coverage, could significantly improve female cancer control in the country.

In the current context of epidemiological transition, demographic changes, changes in consumption and lifestyle habits, and pressure on care costs and organized health systems for acute conditions, the Integrated Care Model by Shortell has become a conceptual reference in the search for new methods to manage chronic conditions by focusing on the health conditions of a given population that must be addressed by a set of institutions organized into networks. Within the last 15 years, cancer has gone from the third- to the second-leading cause of death in the State of São Paulo and has shown a gradual increase in the number of new cases; it has thus become a relevant issue for public health and health management. The model adopted by the State for the organization of the cancer care network was the motivation for this study, which aimed to evaluate the evolution of the model of care for cancer patients within the Unified Health System (Sistema Único de Saúde) based on the integrated care model. Since 1993, the year that cancer was first considered highly complex in the Sistema Único de Saúde by the Ministry of Health, it has been possible to observe a progressive orientation towards the integral and integrated care of patients with cancer. In the State of São Paulo, the active participation of qualified service providers through a Technical Reference Committee showed that experts could contribute to the definition of public policies, thereby providing a technical base for decision making and contributing to the development of clinical management.

Resumo Introdução: O câncer chegou à agenda dos gestores de saúde, provocando-os a pensar em novos modelos de organização do sistema. Objetivo: Estudo da rede oncológica do Sistema Único de Saúde no estado de São Paulo por meio da análise da estrutura da rede instalada e habilitada para tratamento e suas características quanto ao perfil e à distribuição dos estabelecimentos, estrutura e serviços disponíveis e produção mínima anual para a manutenção da excelência. Método: Estudo de caso único e integrado, utilizando dados secundários do Datasus, Inca, RHC e CNES e dados primários de documentos oficiais do Comitê de Referência em Oncologia do Estado de São Paulo. Como parâmetros de referência, a Portaria SAS/MS n. 140 de 2014. Resultados: Em abril de 2013 estavam habilitados 72 estabelecimentos para atendimento de oncologia no SUS. Pelo critério populacional, o estado possuía um serviço habilitado para cada 581.961 habitantes, distribuídos de forma desigual pelas 17 RRAS. Com relação à estrutura e aos serviços disponíveis, 80% dos hospitais estavam em conformidade para cirurgias oncológicas, 31% para quimioterapia e 74% para radioterapia. Em relação à produção mínima, 13% dos hospitais estavam conformes em cirurgias oncológicas, 42% em quimioterapia e 14% em radioterapia. Conclusão: A rede instalada apresentava estrutura e tamanho suficiente para atender à demanda de casos novos de câncer, porém havia diferenças regionais e ampla variação de produção entre os serviços, o que provavelmente impactava no acesso dos pacientes, promovia a criação de filas de espera ao mesmo tempo que havia serviços com ociosidade nas instalações.

Summary Introduction: Cancer has now become part of the agenda of health managers, prompting them to consider new models of system organization. Objective: To study the cancer care network of the Brazilian public health system (SUS, in the Portuguese acronym) in the state of São Paulo by analyzing the structure of the installed and enabled network for treatment and its characteristics. Method: A single, integrated case study. We used secondary data from the following sources: Datasus, Inca, RHC and CNES, and primary data from official documents from the Reference Committee on Oncology of the State of Sao Paulo. We used the official guidelines to able services from the National Health Department to make comparison. Results: According to the CNES, in April, 2013 there were 72 cancer care services authorized by SUS in the state of Sao Paulo. Using the population criterion, the state had one service enabled for every 581,961 inhabitants, in an unequal distribution throughout the 17 health care regions. In terms of available structure and services, 80% of the hospitals were compliant for cancer surgery, 31% for chemotherapy and 74% for radiotherapy. In terms of minimum production, only 13% of hospitals were compliant with cancer surgery, 42% with chemotherapy and 14% with radiotherapy. Conclusion: The installed network proved to have sufficient size and structure to meet the demand from new cancer cases. However, there were both regional differences, as well as a wide variation in productivity between services, which probably had an impact on patient access.